Nigeria’s Fidson Pharmaceuticals Secures Global Licence for Generic Influenza Antiviral Production

Nigeria’s Fidson Pharmaceuticals has made a significant stride in the pharmaceutical industry with its selection as one of the manufacturers for a generic influenza antiviral under a global licence. This groundbreaking news was revealed by Premium Times Nigeria, a reputable Nigerian publication. The company is part of an exclusive group of manufacturers from Brazil, China, India, Indonesia, Malaysia, Nigeria, Uganda, Ukraine, and Vietnam that have been chosen to produce the generic antiviral. This move is expected to bolster Nigeria’s position in the global pharmaceutical market and improve access to essential medicines for Nigerians. The exact timeline for the initiation of this project has not been disclosed yet by Fidson Pharmaceuticals.

Sources:
[Premium Times Nigeria](https://www.premiumtimesng.com/health/health-news/914374-nigerian-drugmaker-fidson-selected-to-manufacture-generic-influenza-antiviral-under-global-licence.html)